80199 Drug screening quantitative tiagabine
Also known as: tiagabine level, Gabitril level
Laboratory quantitative drug screen for tiagabine to assess serum level for therapeutic drug monitoring in seizure management.
In Plain Language
tiagabine blood test; seizure medication level
Clinical Context
Monitors tiagabine levels in epilepsy; gamma-aminobutyric acid reuptake inhibitor with varied kinetics.
RVU Information
CPT 80199 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 80199?
CPT 80199 (Drug screening quantitative tiagabine) is a Pathology & Lab code. Laboratory quantitative drug screen for tiagabine to assess serum level for therapeutic drug monitoring in seizure management.
Who uses CPT code 80199?
CPT 80199 is used by Pathology, Neurology, Clinical Pharmacology. Monitors tiagabine levels in epilepsy; gamma-aminobutyric acid reuptake inhibitor with varied kinetics.
When is CPT 80199 used?
Monitors tiagabine levels in epilepsy; gamma-aminobutyric acid reuptake inhibitor with varied kinetics.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.